Description
Apcalis-SX oral jelly (Tadalafil) 20 mg
Apcalis-SX oral jelly is a tadalafil product presented as an oral jelly. Tadalafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used in the management of erectile dysfunction. Verified regulatory sources for tadalafil also support use in benign prostatic hyperplasia in some formulations, but the specific marketed product name here could not be independently verified from official sources, so this description focuses on tadalafil as the active ingredient.
Active Ingredient and Medicine Class
The verified active ingredient is tadalafil, a PDE5 inhibitor. This medicine class increases blood flow in certain tissues by enhancing the nitric oxide–cGMP signaling pathway. Tadalafil is available in multiple oral formulations; some regulatory labels describe tablet products, while this product is an oral jelly presentation.
Established Medical Uses
Regulatory labeling supports tadalafil for erectile dysfunction. Some approved products also include benign prostatic hyperplasia and erectile dysfunction associated with benign prostatic hyperplasia. These uses are based on official prescribing information and should not be assumed for every brand or formulation without product-specific verification.
How It Works
Tadalafil inhibits PDE5, the enzyme that breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP, it helps relax smooth muscle in penile tissue during sexual stimulation and supports increased blood flow needed for an erection. Human review literature describes this as the main pharmacologic basis for tadalafil’s effect in erectile dysfunction.
Important Safety Information
Tadalafil must not be used with nitrates, because the combination can cause a marked drop in blood pressure. Official labels also warn about interactions with alpha-blockers, some antihypertensives, substantial alcohol intake, and potent CYP3A4 inhibitors such as ritonavir, ketoconazole, and itraconazole. It should not be combined with other PDE5 inhibitors or other erectile dysfunction therapies. Use is also inappropriate when sexual activity is medically inadvisable because of cardiovascular status. Caution is advised in significant renal or hepatic impairment.
Possible Side Effects
Commonly reported adverse effects include headache, dyspepsia, back pain, myalgia, nasal congestion, and flushing. Important serious reactions include priapism, sudden vision or hearing changes, symptomatic hypotension, and hypersensitivity reactions.
Scientific Evidence
Peer-reviewed reviews and clinical summaries report that tadalafil improves erectile function across a broad range of patients with erectile dysfunction and is generally well tolerated. Evidence also supports its longer duration of action compared with some other PDE5 inhibitors, which may allow greater flexibility in timing for sexual activity. Reviews of tadalafil have also examined its role in lower urinary tract symptoms associated with benign prostatic hyperplasia.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or individual assessment by a qualified healthcare professional.
Medical Sources
- U.S. Food and Drug Administration, CIALIS (tadalafil) tablets, for oral use — Prescribing Information
- FDA, CHEWTADZY (tadalafil) chewable tablets — Prescribing Information
- Meuleman EJ, Review of tadalafil in the treatment of erectile dysfunction, Expert Opinion on Pharmacotherapy, 2003. PubMed article
